Psoriasis Clinical Trials

Showing 661-680 of 1,026 trials

Evaluation of the Efficacy and Safety of Indigo Naturalis Oil Extract on Psoriatic Nails

NCT00999687

The purpose of this study is to evaluate efficacy and safety of indigo naturalis oil extract in treating nail psoriasis.

Nail Psoriasis

Chang Gung Memorial Hospital31 participantsStarted Sep 2009

UNKNOWNNA

The Effect of NB-UVB on Interleukin-36 Levels in Psoriasis

NCT03526705

Psoriasis is an immune-mediated skin disease that affects 1-2 % of the population. Several cytokines have been found to be involved in the complex pathogenesis of this disease. Il- 36 is one of the cytokines sharing in psoriasis pathogenesis, as its levels are elevated in psoriatic plaques. Cathepsin G is known to activate Il- 36 and promote inflammation in psoriasis.NB-UVB is one of the important treatment modalities for psoriasis. The aim of this study is to detect the effect of NB-UVB on the lesional levels of IL-36 in psoriasis.

Psoriasis

Cairo University25 participantsStarted Jul 2019

COMPLETEDPhase 3

Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis or Psoriatic Arthritis

NCT02986139

The primary objective was to assess the injection site pain associated with the new formulation of etanercept compared with commercial etanercept in adults with rheumatoid arthritis (RA) or psoriatic arthritis (PsA) as measured by a visual analog scale (VAS).

Arthritis, Rheumatoid; Arthritis, Psoriatic

Amgen111 participantsStarted Nov 2016

Birmingham, Alabama, United States • El Cajon, California, United States • Lomita, California, United States +27 more locations

Evaluation of the Efficacy and Safety of Indigo Naturalis Oil Extract on Psoriatic Nails

The Effect of NB-UVB on Interleukin-36 Levels in Psoriasis

Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis or Psoriatic Arthritis

Related Searches

Effect of Brodalumab Compared to Placebo on Vascular Inflammation in Moderate-to-severe Psoriasis

Secukinumab Dosage Optimisation in Partial Responders With Moderate to Severe Plaque-type Psoriasis

A Belgian Registry of HUMIRA® (Adalimumab) in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis ( ProAct )

Uses of Gamma Irradiated Amniotic Membrane as an Alternative Method in Psoriasis Treatment

Acitretin or Tazarotene Gel and Excimer Laser for Treatment of Psoriasis

A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.

A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta

A Trial of a Botanical Drug (EISO) for Treatment of Mild-to-Moderate Plaque Psoriasis

A Study to Investigate Safety With Risankizumab in Psoriatic Arthritis Subjects Who Have Completed Week 24 Visit of Study M16-002 (NCT02719171)

Oral Chinese Herbal Medicine for Psoriasis Vulgaris With Blood Heat Syndrome

BI 655066 (Risankizumab) Compared to Placebo in Japanese Patients With Moderate to Severe Chronic Plaque Psoriasis

Fire Needle Therapy on Plaque Psoriasis With Blood Stasis Syndrome

Moving Cupping for Plaque Psoriasis: a Randomized Controlled Trial

Plaque Psoriasis Efficacy and Safety With Secukinumab

Efficacy of Re-treatment With Cimzia® in Subject With Chronic Plaque Psoriasis

Study to Determine if AZD0284 is Effective and Safe in Treating Plaque Psoriasis

Role of Topical Treatments in the Modulation of Skin Microbiome in Psoriatic Skin